Hamlet BioPharma Announces Annual General Meeting
Bitget2026/10/23 07:01- Hamlet BioPharma will hold its annual general meeting at High Court in Malmö on November 20, 2026.
- Shareholders will vote on authorizing share, warrant and/or convertible issuance totaling up to 10% of registered shares when the authorization is first used.
- The authorization would run until the next annual meeting, allowing issuance without shareholder preemptive rights to support financing, broaden ownership or enable acquisitions.
- The board proposes no dividend for fiscal 2025/2026, with the result carried forward.
- Major shareholders propose reelecting all four board members, retaining Catharina Svanborg as chair.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese stocks fall below 57,000 points
Texas Governor-Elect: Data centers must be suspended until measures to protect the interests of the people are introduced
The newly elected governor of Texas, Hinojosa, publicly stated that she despises the way data centers "take advantage of Texans" and that any measures must be paused before the introduction of new data centers. She also expressed willingness to collaborate with tech giants such as Elon Musk but emphasized that "it must be on our terms." Goldman Sachs previously warned that the current "blue wave" could result in a suspension order affecting the expansion capacity of approximately 45% of data centers across the United States, with Texas accounting for about 25%. Other states are also rushing to follow Texas' lead.
DIFC Court proposes establishing an oracle to enforce tokenized asset court rulings
Crypto prices
More
